FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula (IVa-2), or to their pharmaceutically acceptable salts, tautomers or deuterated analogs. In formula (IVa-2), the radicals and symbols have the definitions given in the claims. Compounds of formula (IVa-2) are active against c-kit protein kinases or c-kit mutant protein kinases having any of the mutations described herein. 
.
EFFECT: methods for the preparation and use of these compounds for the treatment of diseases and conditions associated with aberrant activity of c-kit protein kinases and / or c-kit mutant protein kinases are also described.
20 cl, 3 tbl, 26 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROCYCLIC COMPOUNDS AND USES THEREOF | 2014 |
|
RU2680100C9 |
| COMPOUNDS MODULATING C-FMS AND/OR C-KIT ACTIVITY AND USE THEREOF | 2007 |
|
RU2452738C2 |
| NEW COMPOUNDS AND COMPOSITIONS FOR NAMPT INHIBITION | 2011 |
|
RU2617988C2 |
| KINASES MODULATION AND INDICATIONS FOR ITS USE | 2012 |
|
RU2631487C2 |
| USING EP4 RECEPTOR ANTAGONISTS IN TREATING IL-23-MEDIATED DISEASES | 2011 |
|
RU2571816C2 |
| NOVEL PHOSPHATE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2617682C2 |
| BENZOPYRAZINE AND BENZOXEPINE PI3K INHIBITORS AND USE THEREOF | 2009 |
|
RU2506267C2 |
| PREPARATION AND USE OF KINASE INHIBITOR | 2016 |
|
RU2691401C2 |
| PYRROL[2,3-B]PYRAZINES AS SYK INHIBITORS | 2013 |
|
RU2656853C2 |
| NOVEL PYRROLE COMPOUNDS, SYNTHESIS METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | 2014 |
|
RU2607788C2 |
